Androgen receptor immunohistochemistry on paraffin-embedded tissue

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• Androgen deprivation therapy is standard for metastatic prostate cancer, but treatment response varies.
• Androgen receptor (AR) expression predicts response, yet detection methods are limited and controversial.
• Existing AR detection methods use frozen tissues, leading to contamination and limited study scope.

Purpose of the Study:

• To develop and validate a reliable method for assessing androgen receptor (AR) expression in formalin-fixed, paraffin-embedded prostate cancer tissues.
• To enable the use of routinely processed archival tissues for AR analysis.
• To facilitate studies correlating AR expression with endocrine therapy response in advanced prostate cancer.

Main Methods:

• Developed an immunohistochemical technique using antigen retrieval for formalin-fixed, paraffin-embedded tissue sections.
• Evaluated AR expression in primary and metastatic prostate carcinomas, normal prostatic glands, and stromal cells.
• Tested the specificity of the method on other cancer types (colon, breast, lung, skin, kidney).

Main Results:

• Nuclear staining for ARs was observed in primary and metastatic prostate carcinomas.
• Normal and hyperplastic prostatic secretory cells showed uniform nuclear AR staining.
• Stromal cells exhibited strong nuclear AR positivity; other tested cancers were negative for AR.

Conclusions:

• The described immunohistochemical technique provides a simple and effective way to evaluate AR status in routinely processed prostate cancer tissues.
• This method allows for the assessment of AR expression in archival samples.
• Further application of this technology can clarify the predictive value of AR expression for endocrine therapy response in advanced prostate cancer.